Figure 1
Outline of the study design. All enrolled individuals were assessed by GCGR and GLP1R PET both at baseline and after 3 weeks treatment with SAR425899.
Figure 1 | Scientific Reports
Outline of the study design. All enrolled individuals were assessed by GCGR and GLP1R PET both at baseline and after 3 weeks treatment with SAR425899.
